F.D.A. Authorizes Novavax’s Covid-19 Vaccine, a Latecomer

The vaccine was authorized as a primary immunization series for adults, rather than a booster, which may limit its market at first.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *